Your session is about to expire
← Back to Search
Patient Navigation for Lung Cancer
N/A
Waitlist Available
Led By Travis P Baggett, MD, MPH
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months (26 weeks) plus guideline-recommended follow-up timeframe plus 1 month (4 weeks)
Awards & highlights
Study Summary
This trial will test whether patient navigation can help homeless-experienced people overcome their unique barriers to obtaining lung cancer screening.
Eligible Conditions
- Lung Cancer
- Homelessness
- Tobacco Use
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months (26 weeks) plus guideline-recommended follow-up timeframe plus 1 month (4 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months (26 weeks) plus guideline-recommended follow-up timeframe plus 1 month (4 weeks)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number (percentage) of participants who receive low-dose computed tomography (LDCT) for lung cancer screening (LCS) at 6 months (26 weeks).
Secondary outcome measures
Number (percentage) of participants who receive low-dose computed tomography (LDCT) for lung cancer screening (LCS) at 6 months (26 weeks) with diagnostic follow-up of abnormal results within 1 month (4 weeks) of the recommended time frame.
Other outcome measures
Time to completion of low-dose computed tomography (LDCT) for lung cancer screening (LCS)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Usual care with patient navigationExperimental Treatment1 Intervention
Participants assigned to this arm will be informed about lung cancer screening (LCS), provided educational materials on LCS and patient navigation, and offered access to an LCS navigator who will partner with participants and primary care providers (PCPs) to facilitate low-dose computed tomography (LDCT) completion and follow-up.
Group II: Usual care without patient navigationActive Control1 Intervention
Participants assigned to this arm will be given basic educational materials on general lung health and referred back to their primary care provider (PCP) for management as per usual practice.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
2017
Completed Phase 2
~38910
Find a Location
Who is running the clinical trial?
American Cancer Society, Inc.OTHER
224 Previous Clinical Trials
110,196 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,925 Previous Clinical Trials
13,197,643 Total Patients Enrolled
Travis P Baggett, MD, MPHPrincipal InvestigatorMassachusetts General Hospital
1 Previous Clinical Trials
83 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Do elderly patients fit the age range for this clinical trial?
"In order to participate in this experiment, individuals must be aged 55 to 77. There are 59 clinical trials that have a lower age limit and 1698 that have an upper age limit."
Answered by AI
To whom does this trial give the opportunity to participate?
"For this particular trial, we are looking for 300 individuals aged 55 to 77 who have a history of tobacco use. Furthermore, these individuals must also: Have a Boston Health Care for the Homeless (BHCHP) primary care provider (PCP), Currently or formerly homeless, Have a 30 pack-year smoking history and have smoked within the past 15 years."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger